Quintiles, Inc. and Kaiser Permanente Announce Alliance to Accelerate Drug Development
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Quintiles, the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide, and Kaiser Permanente’s Southern California Permanente Medical Group (SCPMG) today announced an agreement to help accelerate the development of new and more effective medicines.